NATCOPHARM.BONATCOPHARM.BOBSE
Loading
P/E Ratio: Discounted ValuationCompressed
Percentile Rank0
3Y CAGR-54.5%
5Y CAGR-17.5%
Studio
Year-over-Year Change

Price-to-earnings ratio

3Y CAGR
-54.5%/yr
vs +42.4%/yr prior
5Y CAGR
-17.5%/yr
Recent deceleration
Acceleration
-96.9pp
Decelerating
Percentile
P0
Near historical low
vs 5Y Ago
0.4x
Contraction
Streak
3 yr
Consecutive declineCompressed
PeriodValueYoY Change
20257.65-39.3%
202412.59-12.4%
202314.38-82.3%
202281.13+137.4%
202134.17+70.7%
202020.01+23.5%
201916.21-17.8%
201819.71-35.3%
201730.47-33.1%
201645.55-